Melatonin is much more than a sleep hormone – it is one of the body’s most potent natural antioxidants.
Human ovarian follicles naturally contain melatonin at concentrations higher than those found in the bloodstream.
Oxidative stress is believed to be one of the major contributors to declining egg quality as women age.
Clinical studies suggest this hormone may improve oocyte (egg) maturation, fertilization rates, and embryo quality in women undergoing IVF.
Current evidence is promising but does not yet conclusively show that the hormone improves live birth rates or natural conception.
Melatonin should be considered one component of a comprehensive fertility treatment plan rather than a standalone therapy.

If Melatonin Helps You Sleep, Could It Also Help Your Eggs?

When most people think about melatonin, they think about sleep.

However, over the past two decades, reproductive medicine researchers have become increasingly interested in this compound for an entirely different reason: its remarkable ability to protect eggs from oxidative damage. Research has shown that melatonin is naturally concentrated inside ovarian follicles – the fluid-filled structures where eggs mature – and may play an important role in preserving egg quality. (Springer Link)

As women age, oxidative stress increases while the body’s natural antioxidant defences gradually decline. Since a woman is born with all of the eggs she will ever have, these cells must remain healthy for decades before ovulation occurs. Unlike many other cells in the body, eggs cannot simply be replaced if they become damaged.

This has led scientists to investigate whether increasing melatonin levels might help protect developing eggs from oxidative stress and improve fertility outcomes.

The results are encouraging – but also more nuanced than many internet articles suggest.

As a naturopathic doctor focused on fertility in Toronto, I believe patients deserve an evidence-based understanding of where it may be helpful, where evidence is still emerging, and whether it might be appropriate as part of an individualized fertility treatment plan.

Why Egg Quality Matters More Than Egg Quantity

Many women understandably focus on ovarian reserve tests such as AMH (Anti-Müllerian Hormone) or antral follicle count. While these tests estimate the number of remaining eggs, they tell us very little about their quality.

Egg quality refers to an oocyte’s ability to:

complete normal maturation
undergo successful fertilization
divide normally after fertilization
produce a chromosomally normal embryo
implant successfully
develop into a healthy pregnancy.

As women age, chromosome abnormalities become increasingly common.

Approximately:

about 30% of embryos are chromosomally abnormal before age 35
approximately 50–60% by age 40
over 80% after age 43

Although age is the strongest determinant of egg quality, it is not the only factor.

Other contributors include:

oxidative stress
mitochondrial dysfunction
chronic inflammation
smoking
obesity
insulin resistance
endometriosis
environmental toxin exposure
poor sleep and circadian disruption. (ScienceDirect)

Many of these factors have one thing in common – they increase oxidative damage within the ovarian follicle.

What Is Oxidative Stress?

Every cell in the body continuously produces reactive oxygen species (ROS) during normal metabolism.

These highly reactive molecules are not inherently harmful.

In fact, controlled amounts are necessary for:

ovulation
hormone production
follicular development
cellular signaling
fertilization.

Problems arise when reactive oxygen species are produced faster than antioxidants can neutralize them.

This imbalance is known as oxidative stress.

Excess oxidative stress can damage:

DNA
mitochondria
cell membranes
proteins
chromosomes.

Egg cells are particularly vulnerable because they remain metabolically active for many years before ovulation.

Unlike skin or intestinal cells, damaged eggs cannot simply be replaced.

For this reason, maintaining antioxidant protection inside ovarian follicles appears to be critical for preserving fertility. (J-STAGE)

The Ovary Is Naturally Rich in Melatonin

One of the most surprising discoveries in reproductive biology is that melatonin is highly concentrated within ovarian follicles.

Researchers have consistently found that follicular fluid contains concentrations of the hormone significantly higher than those found in circulating blood. This appears to occur through both active uptake from the bloodstream and local production within the ovary itself. (Springer Link)

Why would the ovary accumulate such large amounts?

The leading explanation is protection.

Ovulation is an inflammatory process that naturally generates free radicals. Without sufficient antioxidant defences, these free radicals can damage the developing egg at one of the most critical stages of maturation.

Melatonin helps counteract this process through several mechanisms.

How Melatonin May Protect Egg Quality

This antioxidant hormone is unusual because it acts through multiple complementary pathways rather than a single mechanism.

1. It Directly Neutralizes Free Radicals

Melatonin is one of the body’s most effective endogenous antioxidants.

Unlike many antioxidants that neutralize only one type of reactive oxygen species, it scavenges multiple oxygen- and nitrogen-derived free radicals.

Even more importantly, the breakdown products formed after this antioxidant hormone neutralizes free radicals continue acting as antioxidants themselves – a phenomenon known as the antioxidant cascade. (J-STAGE)

2. It Supports the Body’s Own Antioxidant Systems

Melatonin doesn’t simply provide antioxidant activity itself.

It also stimulates several important antioxidant enzymes, including:

superoxide dismutase (SOD)
glutathione peroxidase
catalase.

At the same time, it appears to reduce the activity of enzymes that generate excessive reactive oxygen species.

This dual action may provide greater protection than antioxidants that act only by direct scavenging.

3. It Protects Mitochondria

Every egg contains hundreds of thousands of mitochondria.

These tiny structures generate ATP – the energy required for:

chromosome separation
fertilization
embryo development
early cell division.

Mitochondrial dysfunction is increasingly recognized as one of the hallmarks of reproductive aging.

Experimental studies suggest that this antioxidant hormone helps preserve mitochondrial function by:

reducing oxidative damage
improving ATP production
stabilizing mitochondrial membranes
reducing programmed cell death (apoptosis). (ScienceDirect)

4. It May Improve Chromosomal Stability

One of the leading causes of miscarriage is chromosomal abnormality. Researchers believe oxidative stress contributes to abnormal chromosome separation during meiosis.

Animal and laboratory studies suggest melatonin helps preserve spindle integrity and chromosome alignment during egg maturation. Although this evidence remains largely preclinical, it offers a biologically plausible explanation for improvements in embryo quality observed in several IVF studies. (PMC)

Does Melatonin Naturally Decline With Age?

Production of the hormone from the pineal gland gradually decreases throughout adulthood.

At the same time:

oxidative stress increases
mitochondrial function declines
DNA repair becomes less efficient
reproductive aging accelerates.

These parallel changes have prompted researchers to investigate whether restoring its levels might help offset some age-related decline in ovarian function.

Importantly, this does not mean melatonin reverses ovarian aging. Rather, the hypothesis is that improved antioxidant protection may allow existing eggs to mature in a healthier follicular environment.

This distinction is important because no supplement has been proven to reverse reproductive aging.

Why Researchers Became Interested in Melatonin for IVF

One of the earliest clinical observations came from studies measuring melatonin concentrations within follicular fluid during IVF cycles.

Researchers found that women with higher follicular concentrations generally had:

lower oxidative stress markers
healthier follicular environments
better fertilization outcomes.

These observations led investigators to ask an important question:

If higher natural melatonin levels are associated with better egg quality, could supplementation improve fertility outcomes?

Over the past two decades, numerous randomized controlled trials have attempted to answer that question, particularly among women undergoing in vitro fertilization.

Some of the findings have been surprisingly encouraging – but others have been more modest than early enthusiasm suggested.

Melatonin and Egg Quality: What Does the Research Actually Show?

Now let’s look at the evidence that matters most: Does taking it as a supplement actually improve fertility outcomes?

The short answer is yes – possibly, but with important limitations.

While melatonin has shown encouraging effects on several measures of egg and embryo quality, particularly in women undergoing in vitro fertilization (IVF), the evidence is stronger for some outcomes than others.

What Is the Highest-Quality Evidence?

When evaluating fertility treatments, randomized controlled trials (RCTs) and systematic reviews of multiple RCTs provide the strongest evidence.

Over the past 20 years, researchers have published:

numerous randomized controlled trials
prospective cohort studies
several systematic reviews
multiple meta-analyses.

Most have focused on women undergoing assisted reproductive technologies (ART), particularly IVF and intracytoplasmic sperm injection (ICSI).

This is important because IVF allows researchers to directly observe outcomes that cannot be measured in natural conception, including:

the number of mature eggs retrieved
fertilization rates
embryo quality
blastocyst development
implantation rates.

These intermediate outcomes provide valuable information about egg quality, even before pregnancy occurs.

What Have Clinical Trials Found?

Although individual studies vary, the overall body of evidence suggests melatonin supplementation may improve several markers of reproductive success.

1. Mature Egg (MII Oocyte) Numbers

One of the most consistent findings is an increase in the proportion of mature eggs (metaphase II oocytes). This is important because only mature eggs can normally be fertilized successfully.

Several randomized trials have found that women taking the supplement before egg retrieval produced:

a greater proportion of mature oocytes
fewer immature eggs
healthier follicular environments with lower oxidative stress.

Not every study has demonstrated a statistically significant benefit, but pooled analyses suggest a modest overall improvement.

For women with diminished ovarian reserve or advanced reproductive age, even small improvements in mature egg numbers may be clinically meaningful.

2. Fertilization Rates

Multiple studies have demonstrated improved fertilization rates following supplementation.

Researchers believe this may result from:

healthier mitochondria
reduced DNA damage
improved spindle integrity
better cytoplasmic maturation.

Meta-analyses generally report higher fertilization rates among women receiving melatonin compared with placebo or standard treatment alone.

Although improvements are modest rather than dramatic, they have been remarkably consistent across many studies.

3. Embryo Quality

Perhaps the strongest evidence relates to embryo quality.

Several randomized trials have demonstrated improvements in:

high-quality embryos
blastocyst formation
embryo morphology.

Embryo grading is not a perfect predictor of pregnancy, but higher-quality embryos generally have greater implantation potential and lower miscarriage rates.

Researchers suspect these improvements reflect healthier eggs before fertilization rather than direct effects on embryos themselves.

4. Oxidative Stress Markers

One advantage of fertility research is that follicular fluid can be analyzed during IVF.

Numerous studies have shown that melatonin supplementation reduces markers of oxidative stress within the ovarian follicle, including:

8-hydroxy-2′-deoxyguanosine (8-OHdG), a marker of oxidative DNA damage
lipid peroxidation products
reactive oxygen species
inflammatory mediators.

At the same time, antioxidant activity, including glutathione and antioxidant enzyme activity, often increases.

These biochemical findings strengthen the biological plausibility that melatonin is exerting beneficial effects directly within the follicular environment.

Does Melatonin Improve Pregnancy Rates?

This is where the evidence becomes more complicated. Many individual trials have reported higher clinical pregnancy rates among women taking this supplement. However, when results from multiple studies are combined, the findings become less consistent. Some meta-analyses demonstrate statistically significant improvements. Others show positive trends that fail to reach statistical significance.

Why?

Several reasons explain the inconsistency. First, pregnancy depends on much more than egg quality.

Successful pregnancy also requires:

healthy sperm
normal embryos
receptive endometrium
proper immune regulation
appropriate hormonal support.

Even if melatonin improves egg quality, other factors may still prevent pregnancy. Second, many studies are relatively small. Several randomized trials include fewer than 100 participants, making it difficult to detect modest improvements.

What About Live Birth Rates?

Patients understandably care most about one outcome:

Does melatonin increase the chance of taking home a healthy baby?

Unfortunately, this remains one of the biggest unanswered questions. Although some studies report higher live birth rates, most have been underpowered to detect meaningful differences.

Recent systematic reviews conclude that evidence for improved live birth remains insufficient, primarily because:

too few studies report live birth
participant numbers remain relatively small
treatment protocols differ substantially between studies.

In other words: The available evidence is encouraging but not yet conclusive. This is an important distinction because improvements in embryo quality do not always translate into higher live birth rates.

As healthcare providers, we should avoid overstating what the current evidence actually shows.

Women With Diminished Ovarian Reserve

Melatonin may be particularly promising for women with diminished ovarian reserve (DOR).

DOR is characterized by:

lower AMH
fewer antral follicles
reduced egg numbers
often reduced egg quality.

A randomized controlled trial published in 2024 demonstrated that women with diminished ovarian reserve who received supplementation experienced:

reduced oxidative stress within follicular fluid
improved mitochondrial function
improved oocyte maturation
better embryo development compared with controls.

Although larger trials are still needed, these findings support the biological rationale for melatonin in women whose ovarian antioxidant defences may already be compromised.

Advanced Maternal Age

Egg quality naturally declines with age.

Beginning in the mid-30s, and accelerating after age 40, eggs become increasingly susceptible to:

oxidative damage
mitochondrial dysfunction
chromosomal abnormalities.

Animal studies consistently show that melatonin reduces many of these age-related changes. Human studies are also encouraging, although the benefits appear modest rather than dramatic. This antioxidant cannot reverse reproductive aging. However, improving the follicular environment may help maximize the quality of the eggs that remain.

This distinction is important when counselling patients.

Women With PCOS

Women with polycystic ovary syndrome (PCOS) often experience increased oxidative stress and chronic low-grade inflammation.

Several studies suggest this hormone may improve:

oxidative stress markers
inflammatory markers
menstrual regularity
oocyte quality during IVF.

Some investigators have also reported improvements in insulin sensitivity, although findings remain inconsistent.

Because oxidative stress appears to contribute to many aspects of PCOS, supplementation of this antioxidant continues to be an active area of research.

Endometriosis

Endometriosis creates an inflammatory environment that may impair egg quality.

Laboratory and animal studies suggest melatonin possesses:

antioxidant
anti-inflammatory
anti-fibrotic properties.

Although early clinical studies are promising, there is currently insufficient evidence to recommend taking this supplement specifically for improving fertility outcomes in women with endometriosis.

Further randomized trials are needed.

Natural Conception Versus IVF

One of the most common misconceptions online is that melatonin has been proven to increase natural fertility. This is not what current research shows. Nearly all of the highest-quality human evidence comes from IVF studies.

Researchers can directly observe eggs, embryos and fertilization in IVF. Those measurements are impossible during natural conception.

As a result, there is currently very little high-quality evidence that melatonin increases natural pregnancy rates in couples trying to conceive without assisted reproduction. That does not mean it cannot help.

Rather, it means we simply do not yet have adequate clinical trials to answer the question.

Why Do Some Studies Show Larger Benefits Than Others?

Several factors likely explain the variability between studies.

These include differences in:

melatonin dose (typically 2–8 mg/day)
duration of supplementation
patient age
ovarian reserve
IVF stimulation protocols
concurrent antioxidant use
study quality.

Some trials combine melatonin with:

myo-inositol
folate
vitamin D
CoQ10
other antioxidants.

This makes it difficult to determine how much of the observed benefit is attributable to taking this alone.

What Do Recent Systematic Reviews Conclude?

The most recent systematic reviews reach remarkably similar conclusions.

Overall, melatonin appears to:

✓ Improve follicular antioxidant status

✓ Reduce oxidative damage

✓ Increase mature oocyte numbers

✓ Improve fertilization rates

✓ Improve embryo quality

Evidence for improving:

clinical pregnancy is promising but inconsistent

Evidence for improving:

live birth remains insufficient.

From an evidence-based perspective, this is an encouraging profile. Melatonin appears biologically plausible, relatively inexpensive, and generally well tolerated.

However, it should still be viewed as an adjunctive therapy rather than a proven fertility treatment.

What This Means for Patients

If you’re considering melatonin because you’re trying to conceive, the current evidence suggests several important take-home messages.

It is not a miracle supplement. It cannot restore ovarian reserve. It cannot reverse age-related chromosomal abnormalities.

It cannot guarantee pregnancy.

However, it may improve the environment in which eggs mature, particularly in women experiencing increased oxidative stress.

For some patients, especially those undergoing IVF, women of advanced reproductive age, or those with diminished ovarian reserve, it may become one useful component of a broader fertility optimization strategy.

The key is individualized treatment rather than assuming every woman trying to conceive will benefit equally.

Melatonin for Fertility: Practical Considerations, Safety, Dosage and Frequently Asked Questions

The evidence suggests that taking this supplement may be a valuable fertility-supportive therapy for some women, particularly those undergoing IVF, women with diminished ovarian reserve, and those with increased oxidative stress.

However, like any intervention, the details matter.

The question most patients ask is:

“Should I take melatonin if I’m trying to improve my fertility?”

The answer depends on your individual fertility picture, health history, medications, sleep patterns, age, ovarian reserve, and whether you are pursuing natural conception or assisted reproductive technology.

How Much Melatonin Should You Take for Fertility?

Most fertility studies have used doses ranging from:

2 mg to 8 mg daily
commonly 3 mg daily
typically taken in the evening before bedtime.

Clinical IVF studies most often begin supplementation several weeks before egg retrieval, allowing time for developing follicles to be exposed to improved antioxidant protection.

A commonly studied approach is:

Melatonin 3 mg nightly, beginning 4-8 weeks before IVF egg retrieval.

However, there is no universally established fertility dose. More is not necessarily better.

This supplement is a hormone, not simply a vitamin or antioxidant supplement. Higher doses can produce unwanted effects in some people, including:

morning grogginess
vivid dreams and nightmares
headaches
dizziness
changes in sleep patterns.

In clinical practice, I generally prefer using the lowest effective dose rather than automatically choosing higher doses.

Immediate Release vs Extended Release Melatonin

Patients often ask whether they should choose immediate-release or extended-release melatonin.

For fertility purposes, most research has used immediate-release melatonin.

Immediate-release:

increases blood levels relatively quickly
more closely mimics the natural nighttime rise of this hormone
is typically taken 30–60 minutes before bedtime.

Extended-release formulations:

maintain blood levels for longer periods
may be useful for some sleep disorders
have not been as extensively studied for fertility outcomes.

Because ovarian follicular exposure is one of the proposed mechanisms of action, the formulation used in research is generally the one clinicians consider when applying evidence to practice.

When Should You Take Melatonin?

Timing is important because the compound is both:

an antioxidant molecule
a circadian hormone.

For fertility support, melatonin is usually taken:

30–60 minutes before bedtime
at approximately the same time every night
in a dark environment.

Light exposure suppresses your own natural melatonin production.

For optimal circadian signalling:

dim lights in the evening
reduce bright screens before bed
use a nightlight in your bathroom
maintain a consistent sleep schedule.

Improving natural production of this hormone through lifestyle habits may complement supplementation.

How Long Before Trying to Conceive Should You Take Melatonin?

Egg development is a long process. Although ovulation occurs monthly, the final stages of follicular maturation occur over several months. For IVF, studies commonly begin melatonin supplementation several weeks before ovarian stimulation.

For natural conception, there are no large clinical trials defining the ideal duration.

Many fertility clinicians consider:

8–12 weeks of preparation

a reasonable timeframe because it aligns with the biology of follicular development.

However, the optimal duration remains unknown.

Is Melatonin Safe When Trying to Conceive?

For most healthy adults, short-term supplementation appears to have a good safety profile. Clinical trials involving women undergoing IVF have generally reported few adverse effects.

Potential side effects include:

daytime sleepiness
dizziness
headache
nausea
vivid dreams or nightmares
changes in sleep quality.

Because melatonin influences reproductive hormones and circadian biology, anyone actively trying to conceive should ideally discuss supplementation with their healthcare provider.

Is Melatonin Safe During Pregnancy?

This is one of the most important questions patients ask.

The answer is:

We do not yet have enough high-quality evidence to routinely recommend melatonin supplementation during pregnancy. Avoid using it during pregnancy.

Although preliminary studies have explored melatonin in pregnancy-related conditions, including oxidative stress disorders, pregnancy safety data remain incomplete.

If pregnancy occurs while taking melatonin, do not panic, but discontinue it as soon as you find out that you are pregnant.

Can Men Take Melatonin for Fertility?

Although this article focuses on egg quality, fertility is a shared process. Male infertility contributes to approximately half of infertility cases.

Oxidative stress also affects:

sperm DNA integrity
sperm motility
sperm function.

Preliminary studies suggest melatonin may reduce oxidative damage in sperm, although the evidence is not as robust as the female fertility literature.

Male partners may benefit from evaluation and individualized antioxidant support rather than assuming fertility challenges are solely related to the female partner.

Who May Be Most Likely to Benefit From Melatonin?

Based on current evidence, taking this supplement may be most relevant for women with:

Advanced reproductive age

Women in their late 30s and 40s often experience increased oxidative stress and mitochondrial dysfunction within oocytes.

Melatonin’s antioxidant effects may help optimize the follicular environment.

Diminished ovarian reserve

Women with:

low AMH
reduced antral follicle count
previous poor IVF response

may represent a group where improving egg quality is particularly important.

Previous IVF cycles with poor outcomes

Some clinicians consider melatonin in women with:

poor embryo development
low fertilization rates
increased oxidative stress markers.

High oxidative stress burden

Factors that may increase oxidative stress include:

smoking
chronic inflammation
PCOS
insulin resistance
poor sleep
metabolic dysfunction
environmental toxin exposure.

Addressing these underlying contributors remains essential. How do you know if you have oxidative stress? It’s a good question, and unfortunately, there isn’t a good test for this. But if the above factors apply to you, oxidation is worth addressing.

Who Should Be Cautious With Melatonin?

Melatonin is not appropriate for everyone. Discuss taking it with your healthcare provider if you:

take prescription medications
have autoimmune disease
have epilepsy or seizure disorders
have significant mood disorders
have hormone-sensitive cancers
have liver disease

Do not take it if you are pregnant or breastfeeding.

Potential Drug Interactions

Melatonin may interact with certain medications, including:

Blood thinners

Melatonin may influence blood clotting pathways. Caution is recommended with anticoagulant medications.

Sedating medications

Melatonin may increase drowsiness when combined with:

sleep medications
sedatives
some antihistamines.

Immune-modulating medications

Because melatonin affects immune signalling, caution may be appropriate in individuals taking immunosuppressive medications.

Hormonal medications

Women undergoing fertility treatment should inform their reproductive endocrinologist about all supplements that they are taking.

My Naturopathic Perspective on Melatonin and Fertility

In my fertility patients, I view melatonin as one piece of a much larger picture. Egg quality is influenced by many interconnected systems:

mitochondrial health
blood sugar regulation
inflammation
thyroid function
nutrient status
sleep quality
stress physiology
hormone imbalance
environmental exposures.

A fertility plan should not rely on one supplement. The most effective approach combines:

evidence-based nutrition
correction of nutrient deficiencies
hormone optimization
lifestyle optimization
appropriate and thorough laboratory assessment
targeted supplementation when indicated.

Melatonin is exciting because it addresses a real biological mechanism (oxidative stress), but it works best as part of a comprehensive approach, when the foundation of fertility issues is also addressed.

Frequently Asked Questions About Melatonin and Fertility

1. Does melatonin improve egg quality?

Research suggests melatonin may improve aspects of egg quality by reducing oxidative stress within ovarian follicles. Human IVF studies show improvements in mature egg numbers, fertilization rates, and embryo quality. However, it has not been proven to reverse age-related egg decline.

2. How long should I take melatonin before IVF?

Most clinical studies begin supplementation several weeks before egg retrieval. Many protocols use approximately 4-8 weeks of supplementation, although the optimal duration has not been established.

3. Can melatonin help me get pregnant naturally?

There is currently insufficient evidence that melatonin increases natural conception rates. The underlying fertility issues need to be addressed and resolved. Most research has been conducted in IVF patients.

4. Does melatonin increase AMH?

No. It has not been shown to increase ovarian reserve markers such as AMH. Its potential benefit appears related to improving the follicular environment rather than increasing egg numbers.

5. Can melatonin improve embryo quality?

Several IVF studies suggest improved embryo quality with supplementation, likely through reduced oxidative stress and improved mitochondrial function.

6. Can melatonin prevent miscarriage?

There is currently insufficient evidence to recommend this supplement specifically for miscarriage prevention. Theoretically, antioxidants like this that improve egg quality may help prevent miscarriage when other fertility factors are addressed.

7. Does melatonin help women over 40 get pregnant?

Melatonin may be particularly relevant for older reproductive age because oxidative stress contributes to egg aging. However, it cannot eliminate the effects of aging on egg chromosomes.

8. Is melatonin better than CoQ10 for egg quality?

Melatonin and CoQ10 work through different pathways.

While CoQ10 is also an antioxidant, it primarily supports mitochondrial energy production, while melatonin provides antioxidant and circadian support.

Some fertility protocols use both, although research has not definitively determined the optimal combination.

9. Can I take melatonin with prenatal vitamins?

For many people, melatonin can be combined with prenatal vitamins. However, individual circumstances and other supplements should be reviewed with a healthcare professional.

10. Does melatonin affect fertility hormones?

Melatonin interacts with reproductive hormone pathways, including ovarian function and gonadotropin signalling. In IVF studies, it has generally not caused harmful hormonal changes, but individualized assessment is appropriate.

11. Should my partner take melatonin too?

Male fertility is also affected by oxidative stress. Some evidence suggests potential benefits for sperm health, but men should receive individualized fertility assessment and supplement guidance.

12. Can melatonin delay ovulation?

There is no strong evidence that typical supplemental doses delay ovulation in healthy women.

13. Is melatonin safe with fertility medications?

Many IVF studies have used melatonin alongside fertility medications without major safety concerns. However, your fertility specialist should be advised about every supplement you take.

14. What is the best brand of melatonin?

Quality matters because supplements are not regulated identically worldwide. Per the College of Naturopaths of Ontario regulations, I cannot publicly endorse any particular brand of supplements. In my one-on-one visits, I will specify good quality brands for supplements like melatonin. Look for products with:

independent quality testing
accurate dosing
minimal unnecessary additives.

15. Is melatonin a fertility treatment?

No. Melatonin should be considered a supportive therapy that may optimize conditions for fertility. It is not a replacement for thorough evaluation or treatment of infertility causes.

Final Thoughts

The science behind melatonin and fertility is one of the more fascinating developments in reproductive medicine.

Research has revealed that the ovary is not simply a passive organ waiting for ovulation; it actively creates a protective antioxidant environment to support egg maturation. Melatonin appears to be an important part of that environment.

The strongest evidence currently supports melatonin as a potential tool for improving:

follicular antioxidant status
egg maturation
fertilization rates
embryo quality.

However, questions remain about its ability to improve live birth rates or enhance natural conception.

For women trying to conceive, the goal should not be finding a single “fertility supplement.” The goal should be creating the healthiest possible environment for egg development, implantation, and pregnancy. That means comprehensive testing, followed by targeted and appropriate science-based natural treatment.

Melatonin may be one valuable piece of that strategy when used thoughtfully and as part of a comprehensive fertility plan.

References

Tamura H, Takasaki A, Taketani T, Tanabe M, Kizuka F, Lee L, Tamura I, Maekawa R, Asada H, Yamagata Y, Sugino N. Melatonin as a free radical scavenger in the ovarian follicle. Endocr J. 2013;60(1):1-13. doi: 10.1507/endocrj.ej12-0263. Epub 2012 Dec 22. PMID: 23171705.
Sadeghpour, Sonia & Ghasemnejad Berenji, Morteza & Maleki, Farzad & Behroozi-Lak, Tahereh & Bahadori, Robabeh & Ghasemnejad, Hojat. (2025). The effects of melatonin on follicular oxidative stress and art outcomes in women with diminished ovarian reserve: a randomized controlled trial. Journal of Ovarian Research. 18. 10.1186/s13048-024-01584-0.
Tong J, Sheng S, Sun Y, Li H, Li WP, Zhang C, Chen ZJ. Melatonin levels in follicular fluid as markers for IVF outcomes and predicting ovarian reserve. Reproduction. 2017 Apr;153(4):443-451. doi: 10.1530/REP-16-0641. Epub 2017 Jan 6. PMID: 28062641.
Li Q, Zheng T, Chen J, Li B, Zhang Q, Yang S, Shao J, Guan W, Zhang S. Exploring melatonin’s multifaceted role in female reproductive health: From follicular development to lactation and its therapeutic potential in obstetric syndromes. J Adv Res. 2025 Apr;70:223-242. doi: 10.1016/j.jare.2024.04.025. Epub 2024 Apr 30. PMID: 38692429; PMCID: PMC11976432.
Tang H, Hao J, Xu B, Wang Y, Li Y, Zhao J. Melatonin supplementation and outcomes of assisted reproductive technology: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2025 Nov 25;26(1):9. doi: 10.1186/s12884-025-08503-1. PMID: 41286761; PMCID: PMC12764091.
Seko LM, Moroni RM, Leitao VM, Teixeira DM, Nastri CO, Martins WP. Melatonin supplementation during controlled ovarian stimulation for women undergoing assisted reproductive technology: systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2014 Jan;101(1):154-161.e4. doi: 10.1016/j.fertnstert.2013.09.036. Epub 2013 Oct 29. PMID: 24182414..
Yong W, Ma H, Na M, Gao T, Zhang Y, Hao L, Yu H, Yang H, Deng X. Roles of melatonin in the field of reproductive medicine. Biomed Pharmacother. 2021 Dec;144:112001. doi: 10.1016/j.biopha.2021.112001. Epub 2021 Oct 6. PMID: 34624677.
Espino J, Bejarano I, Ortiz A, Lozano GM, García JF, Pariente JA, Rodríguez AB. Melatonin as a potential tool against oxidative damage and apoptosis in ejaculated human spermatozoa. Fertil Steril. 2010 Oct;94(5):1915-7. doi: 10.1016/j.fertnstert.2009.12.082. Epub 2010 Feb 12. PMID: 20152967.
Tang H, Hao J, Xu B, Wang Y, Li Y, Zhao J. Melatonin supplementation and outcomes of assisted reproductive technology: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2025 Nov 25;26(1):9. doi: 10.1186/s12884-025-08503-1. PMID: 41286761; PMCID: PMC12764091.
Manchester LC, Coto-Montes A, Boga JA, Andersen LP, Zhou Z, Galano A, Vriend J, Tan DX, Reiter RJ. Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res. 2015 Nov;59(4):403-19. doi: 10.1111/jpi.12267. Epub 2015 Sep 11. PMID: 26272235.
Reiter RJ, Rosales-Corral SA, Manchester LC, Tan DX. Peripheral reproductive organ health and melatonin: ready for prime time. Int J Mol Sci. 2013 Apr 2;14(4):7231-72. doi: 10.3390/ijms14047231. PMID: 23549263; PMCID: PMC3645684.
Fernando S, Rombauts L. Melatonin: shedding light on infertility? A review of the recent literature. J Ovarian Res. 2014 Oct 21;7:98. doi: 10.1186/s13048-014-0098-y. PMID: 25330986; PMCID: PMC4209073.

Melatonin and Egg Quality: Can It Improve Fertility?

Key Takeaways